The Compound Method
Free guide
Dr. Jennifer Bennett, PharmD
Why I wrote this: Owners are hearing about peptides from providers, patients, and Facebook groups. Most of what's out there skips the parts that keep your pharmacy out of trouble: compounding within the law, keeping good records, and being careful about what you say in public.
This sheet is meant to help you think it through. It isn't a dosing guide, and not every peptide request can be compounded.
Three buckets (keep these straight)
1. Patient-specific 503A
Valid Rx for an identified patient
Compound only when clinical need and legal pathway support it
Document rationale, source, lot, BUD, counseling
2. Office-use / gray asks
Many "for the clinic fridge" asks are not a free pass
State rules and federal limits differ; verify before you ship
If it feels like resale inventory, stop and check
3. Research / consumer gray market
"For research only" websites are not your clinical model
Do not compete with unlicensed sellers on price or speed
Your edge is licensed triad: provider · pharmacist · patient
4. 503B bridge (when useful)
Outsourcing facility product can cover gaps while you build
Still requires compliant ordering and state rules
I can connect you with American-made 503B partners if this fits
Before vs after category shifts (plain English)
Topic
Owner takeaway
FDA category / shortage lists
What is compoundable for human Rx use can change. Recheck status before you market a molecule. Lists are not marketing copy.
Bulk substances / APIs
Source from legitimate suppliers. Keep COAs. Trace lots. If you cannot defend the source on inspection day, do not make it.
Public claims
Education for providers and pharmacists is different from consumer ads promising fat loss, anti-aging, or "research stacks." Stay off the map that invites complaints.
Telehealth Rx
Valid relationship and state rules still matter. A written fulfillment SOP keeps these from getting lost in your inbox.
Please read: This guide doesn't authorize compounding any specific peptide.
Check current federal and state status, your Board's rules, and your PIC policy before your first batch.
If you're unsure, wait. It's better to hold off than to launch a peptide menu you can't defend.
Owner checklist (print and mark)
We know which asks are patient-specific Rx vs office-use fishing.
We will not publish consumer peptide menus or stack ads.
PIC / owner has a written "we will / will not compound" list reviewed quarterly.
Provider questions go to the pharmacist, not a front-end script promising availability.
If sterile peptide work is required, we either have competence + facility or we bridge / refer.
Documentation trail exists before volume grows.
Next step: If you're thinking about adding cash-pay compounding in the next few months, with or without peptides, fill out the short form and I'll reach out directly to see if I can help.
Want more info? Click here: compoundmethod.net/#info